ClinicalTrials.gg
Status unknownNCT02395861PRORETROUpdated Feb 19, 2019

Prognosis of Brain Reflexes

An interventional study of neuro-electrophysiologic analyses in Adult Patients With Alteration of Consciousness and Admitted Into the Intensive Care Unit (ICU), sponsored by Assistance Publique - Hôpitaux de Paris. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-19.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Feb 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Severe diseases in intensive care unit (ICU) patients are associated with a high mortality rate which nevertheless remains difficult to predict. Recently, the abolition of some brainstem reflexes at clinical examination of ICU patients within the first 24 hours after has been shown of prognostic value in ICU patients requiring sedation. Early abolition of the cough reflex was associated with an increase in mortality and that of the oculocephalic reflex was predictive of coma or delirium after sedation has been stopped. A dysfunction of the brainstem may account for these results and be present in other patient subpopulations, particularly those who do not receive iv sedation or the brain injured patients, who were eluded from the previous study. This dysfunction could take place in the muti-organ failure characteristic of the severe ICU patient. On the other hand, a preliminary study performed on somatosensory evoked potentials has shown that a latency of the P14 wave greater than 16 ms between day 1 and day 3 after admission was associated with death at 28 days. The primary goal of this project is to confirm this hypothesis. By studying the clinical and electrophysiological responses of the brainstem in ICU patients, with or without brain injury, with alteration of consciousness in relation or not with sedation. The other objectives are to determine the correlations between neurophysiological clinical neurological, or neuroradiological data with delirium occurrence.

The main objective of this study is to determine, in ICU patients with or without brain injury and with alteration of consciousness in relation or not with sedation, if abolition of the cough reflex at Day 1 after admission is predictive of mortality at 28 days, independent from cause for admission and severity.

Read the detailed description

Adult Medical or surgical, brain-injured or not, ICU patients requiring invasive mechanical ventilation for at least 48 hours and with alteration of consciousness induced or not by sedatives. Inclusion will take place at the 24th hour (± 12) after admission into the ICU will be enrolled. Those patients with either pregnancy, post anoxic coma, brain death, pre-existing neurologic disease disturbing the interpretation of the brainstem reflexes (Guillain-Barre, myasthenia, gravis, brain tumor, inflammatory or degenerating disease of the posterior fossa, acute peripheral neurologic disease), or declined participation will be excluded.

The measurements will be based on:

D1 : Demographic data, cause for admission, brainstem reflexes, Glasgow Coma Scale score, Confusion Assessment Method for the ICU (CAM-ICU) , Richmond Agitation Sedation Scale (RASS), Behavioral Pain Scale (BPS), simplified index of gravity (IGS 2) score, Sequential Organ Failure Assessment (SOFA) scores, cumulated sedative doses and Secondary Systemic Cerebral Aggressions (ACSOS) parameters D3 : parameters of D1, electrophysiologic analyses: Electroencephalogram (EEG), auditory evoked potentials (EAEP), Somatosensory Evoked Potential (SEP), recording of clinico-biological data, Cognitive evoked potentials (CEP) in patients with consciousness alteration still on mechanical ventilation at day 3.

D1-D28 : date of death, date of extubation, SOFA, CAM-ICU, cumulated doses of sedatives and analgesics, duration of sedation, occurrence of nosocomial pneumonia after Day 2, brain imaging data if available.

D28 : Glasgow Outcome Coma Scale and mini mental state

02

Conditions studied

  • Adult Patients With Alteration of Consciousness
  • Admitted Into the Intensive Care Unit (ICU)
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,578 studies on the registry; 1,030 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult Medical or surgical, brain-injured or not, patients
  • Admitted to the intensive care Unit (ICU)
  • Requiring invasive mechanical ventilation for at least 48 hours
  • With alteration of consciousness induced by sedatives or not
  • Within the 24 hours (± 12) after admission into the ICU

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Post anoxic coma
  • Brain death
  • Pre-existing neurologic disease disturbing the interpretation of the brainstem reflexes (Guillain-Barre, myasthenia, gravis, brain tumor, inflammatory or degenerating disease of the posterior fossa, acute peripheral neurologic disease)
  • Declined participation
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Electrophysiologic analyses

    Other: neuro-electrophysiologic analyses

Interventions

  • Otherneuro-electrophysiologic analyses

    mismatch negativity (MMN) cognitive evoked potentials (CEP) auditory evoked potentials (AEP)

06

What researchers measure

Primary outcomes

  1. Mortality at Day 28

    Time frame: day 28

Secondary outcomes

  1. Neurophysiologic response (P14 latency value greater than 16 ms of the SEP of the median nerve)

    P14 latency value greater than 16 ms of the SEP of the median nerve

    Time frame: day 1 and day 3

07

Study locations

1 of 1 sites recruiting
  • Beaujon Hospital
    Clichy, 92, France
    • Jean Mantz, MD PhD · Contact
    Recruiting
08

References and documents

Publications

  • Bouchereau E, Pruvost-Robieux E, Siami S, Chaffaut C, Bougle A, Gavaret M, Heming N, Sivanandamoorthy S, Zyss J, Degos V, Kandelman S, Righy Shinotsuka C, Benghanem S, Naccache L, Rohaut B, Hermann B, Azabou E, Chevret S, Sharshar T. Altered lower brainstem neurophysiological response is associated with mortality in deeply sedated critically ill patients. Intensive Care Med. 2025 Jun;51(6):1050-1061. doi: 10.1007/s00134-025-07945-7. Epub 2025 Jun 13. PubMed 40512201 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2015, a primary completion of May 2019 and a completion of May 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2015
First posted
Mar 24, 2015
Start
Jul 2015
Primary completionEst.
May 2019
CompletionEst.
May 2019
Last update
Feb 19, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02395861
Responsible party
Sponsor
First posted
Mar 24, 2015
Start date
Jul 2015
Primary completion
May 2019 (estimated)
Completion
May 2019 (estimated)
Last update
Feb 19, 2019

Study contacts

Jean MANTZ, MD PhD
Contact
jean.mantz@bjn.aphp.fr
33+1 40875911

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion